pseudomyxomaperitonei mucinousperitoneal surface metastasis · 2008-12-16 · • ronnett:...
TRANSCRIPT
Pseudomyxoma Peritonei
Mucinous Peritoneal Surface Metastasis
S.C. Bruin
Clinical Research Fellow NKI-AVL
The Netherlands
• PMP is used for a wide range of disease entities
• Ongoing discussion around PMP
–Definitions site of origin
–Histopathology
PMP
• Ronnett: Mucinous material within the peritoneal cavity associated with a mucinous tumor
• Sugarbaker: PMP is a rare disease that results from a primary mucinous appendicealneoplasm
• Bradley: PMP is a clinical term for gelatinous ascites, usually secondary to an appendicealtumor. The pathologic classification has been plagued with controversy and confusing terminology
• Glehen: PMP is a rare disease, usually diagnosed after the discover of "jelly belly" by laparotomy
Definition PMP
What is a Jelly Belly?
• Primary lesion• Appendiceal
• Colorectal
• Appendiceal and colorectal
• Pseudomyxoma peritonei
–Colonic Carcinomatosis??
HIPEC literature reports
• PMP is thought to be mainly associated with a mucinous epithelial neoplasm of the appendix
Primary lesion Appendix
Gobletcellcarcinoma
Signetringcell carcinoma
Mucinous adenocarcinoma
Cystadenocarcinoma
Appendiceal mucinous tumor of uncertain malignant potential
Cystadenoma
Adenoma (serrated)
Appendiceal neoplasms associated with mucinous peritoneal disease
Site of origin
Why not the colon?
• There is confusing nomenclature surrounding PMP
Histopathology
Non-aggressive Aggressive
Histopathology
Low grade, High gradeBradley, Miner, Butterworth, Murphy
Grade 1, 2 and 3Cariker, Gough, Loungnarrath
DPAM, PMCA-i, PMCARonnett
Grading of mucinous peritoneal lesions according to different authors
Peritoneal Lesion
Primary
What do we know?
Cytoreduction plus HIPEC
• Improves survival
Survival predictors
• Completeness of cytoreduction
• Number of affected regions
• Histological characteristics
Aim study
• Correlate clinical-pathologic characteristics to survival
Histological revision
• 269 patients treated with HIPEC
• Colon AND appendiceal
• Evaluated histopathological features
–Extracellulair mucus–Mitotic activity–Cellularity–Cytologic atypia
Histological classification PSM
Peritoneal Carcinomatosis(PCA)
Peritoneal MucinousCarcinomatosis (PMCA)
Disseminated PeritonealAdeno Mucinosis (DPAM)
non-mucinous
mucinous
NON-MUCINOUS
MUCINOUS
Extracel Mucus Mitosis None Little Lots None Little Lots
None None
Sporadic 9
Abundant 60
1-50% None 1
Sporadic 4
Abundant 20
50-90% None
Sporadic 1 2
Abundant 15
>90% None 20 38 3
Sporadic 43 13 1 3
Abundant 6 13 17
Few
Nuclear atypia
Cellularity
Many
Nuclear atypia
Disseminated Peritoneal Adeno Mucinosis DPAM
DPAM
MUCINOUS
NON-MUCINOUS
Extracel Mucus Mitosis None Little Lots None Little Lots
None None
Sporadic 9
Abundant 60
1-50% None 1
Sporadic 4
Abundant 20
50-90% None
Sporadic 1 2
Abundant 15
>90% None 20 38 3
Sporadic 43 13 1 3
Abundant 6 13 17
Few
Nuclear atypia
Cellularity
Many
Nuclear atypia
Peritoneal Mucinous Carcinomatosis PMCA
Disseminated Peritoneal Adeno Mucinosis DPAM
PMCA
MUCINOUS
NON-MUCINOUS
Extracel Mucus Mitosis None Little Lots None Little Lots
None None
Sporadic 9
Abundant 60
1-50% None 1
Sporadic 4
Abundant 20
50-90% None
Sporadic 1 2
Abundant 15
>90% None 20 38 3
Sporadic 43 13 1 3
Abundant 6 13 17
Few
Nuclear atypia
Cellularity
Many
Nuclear atypia
Peritoneal Carcinomatosis PCA
Peritoneal Mucinous Carcinomatosis PMCA
Disseminated Peritoneal Adeno Mucinosis DPAM
PCA
MUCINOUS
NON-MUCINOUS
Extracel Mucus Mitosis None Little Lots None Little Lots
None None
Sporadic 9
Abundant 60
1-50% None 1
Sporadic 4
Abundant 20
50-90% None
Sporadic 1 2
Abundant 15
>90% None 20 38 3
Sporadic 43 13 1 3
Abundant 6 13 17
Few
Nuclear atypia
Cellularity
Many
Nuclear atypia
Peritoneal Carcinomatosis PCA
Peritoneal Mucinous Carcinomatosis PMCA
Disseminated Peritoneale Adeno Mucinosis DPAM
PMCA-intermediate PMCA-I
Conclusion
• PSM from colon and appendicealtumors can be classified into
4 distinguishable groups:
»DPAM» PMCA-i
»PMCA
»PCA
Primary tumor location and type of PSM
71%
DPAM PMCA-i PMCA PCA
9%14%
6%
Appendix
2% 5%
30%
63%
Colon
• PSM from primary colon tumors in 37% mucinous
• DPAM most frequently from a primary appendix tumor
• 29% of primary appendix tumors non-DPAM
P<0,001 univariate
64%
24%
33%
Survival prediction by pathology
Survival analysis
• Significant factors mulitivariate analysis
–Histological Classification (p<0,0001)–Gender (p<0,014)–Number of regions (p<0,008)–Result cytoreduction (p<0,0001)
–HIPEC as first treatment on PSM (p<0,007)–Tumor location (p<0,025)
• Combined in a Nomogram Score
Survival DPAM Male
5424
78
0
57%
54
Survival DPAM Female
0
45
75%
2322
Survival PMCA Male
24 61
85
37%
24 42
66
59%
Survival PMCA Female
PCA
PCA
17 74
91
28%
Summary
• PSM are often mucinous
• DPAM better OS than PMCA and PMCA better than PCA
• Female patients better survival than male in mucinous PSM
• Non-mucinous tumors worse survival
Conclusion
• Histological classification of colorectal AND appendiceal PSM gives prognosticinformation
• PSM should be classified by a standardized protocol
• HIPEC Nomogram provides a tool for individual patient risk assessment
Acknowledgements
Vic Verwaal
Andrew Vincent
Laura van ’t Veer
Loes van Velthuysen